Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study.

MLA

Poleé, Iris N., et al. “Long-Term Survival in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Population-Based Study.” European Journal of Cancer, vol. 172, Sept. 2022, pp. 252–63. EBSCOhost, https://doi.org/10.1016/j.ejca.2022.06.003.

APA

Poleé, I. N., Hermans, B. C. M., van der Zwan, J. M., Bouwense, S. A. W., Dercksen, M. W., Eskens, F. A. L. M., Havekes, B., Hofland, J., Kerkhofs, T. M. A., Klümpen, H.-J., Latten-Jansen, L. M., Speel, E.-J. M., Verburg, F. A., Walenkamp, A. M. E., Geurts, S. M. E., & de Vos-Geelen, J. (2022). Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study. European Journal of Cancer, 172, 252–263. https://doi.org/10.1016/j.ejca.2022.06.003

Chicago

Poleé, Iris N., Bregtje C.M. Hermans, Jan Maarten van der Zwan, Stefan A.W. Bouwense, Marcus W. Dercksen, Ferry A.L.M. Eskens, Bastiaan Havekes, et al. 2022. “Long-Term Survival in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Population-Based Study.” European Journal of Cancer 172 (September): 252–63. doi:10.1016/j.ejca.2022.06.003.